Literature DB >> 27384229

CRISPR: a versatile tool for both forward and reverse genetics research.

Channabasavaiah B Gurumurthy1,2, M'hamed Grati3, Masato Ohtsuka4,5, Samantha L P Schilit6, Rolen M Quadros7, Xue Zhong Liu8,9.   

Abstract

Human genetics research employs the two opposing approaches of forward and reverse genetics. While forward genetics identifies and links a mutation to an observed disease etiology, reverse genetics induces mutations in model organisms to study their role in disease. In most cases, causality for mutations identified by forward genetics is confirmed by reverse genetics through the development of genetically engineered animal models and an assessment of whether the model can recapitulate the disease. While many technological advances have helped improve these approaches, some gaps still remain. CRISPR/Cas (clustered regularly interspaced short palindromic repeats/CRISPR-associated), which has emerged as a revolutionary genetic engineering tool, holds great promise for closing such gaps. By combining the benefits of forward and reverse genetics, it has dramatically expedited human genetics research. We provide a perspective on the power of CRISPR-based forward and reverse genetics tools in human genetics and discuss its applications using some disease examples.

Entities:  

Mesh:

Year:  2016        PMID: 27384229      PMCID: PMC5002245          DOI: 10.1007/s00439-016-1704-4

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  47 in total

Review 1.  Going forward with genetics: recent technological advances and forward genetics in mice.

Authors:  Eva Marie Y Moresco; Xiaohong Li; Bruce Beutler
Journal:  Am J Pathol       Date:  2013-05       Impact factor: 4.307

2.  Generation of gene-modified mice via Cas9/RNA-mediated gene targeting.

Authors:  Bin Shen; Jun Zhang; Hongya Wu; Jianying Wang; Ke Ma; Zheng Li; Xueguang Zhang; Pumin Zhang; Xingxu Huang
Journal:  Cell Res       Date:  2013-04-02       Impact factor: 25.617

3.  High-throughput screening of a CRISPR/Cas9 library for functional genomics in human cells.

Authors:  Yuexin Zhou; Shiyou Zhu; Changzu Cai; Pengfei Yuan; Chunmei Li; Yanyi Huang; Wensheng Wei
Journal:  Nature       Date:  2014-04-09       Impact factor: 49.962

Review 4.  High-throughput functional genomics using CRISPR-Cas9.

Authors:  Ophir Shalem; Neville E Sanjana; Feng Zhang
Journal:  Nat Rev Genet       Date:  2015-04-09       Impact factor: 53.242

5.  In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy.

Authors:  Christopher E Nelson; Chady H Hakim; David G Ousterout; Pratiksha I Thakore; Eirik A Moreb; Ruth M Castellanos Rivera; Sarina Madhavan; Xiufang Pan; F Ann Ran; Winston X Yan; Aravind Asokan; Feng Zhang; Dongsheng Duan; Charles A Gersbach
Journal:  Science       Date:  2015-12-31       Impact factor: 47.728

Review 6.  Mouse models of human disease. Part I: techniques and resources for genetic analysis in mice.

Authors:  M A Bedell; N A Jenkins; N G Copeland
Journal:  Genes Dev       Date:  1997-01-01       Impact factor: 11.361

Review 7.  The application of genome editing in studying hearing loss.

Authors:  Bing Zou; Rahul Mittal; M'hamed Grati; Zhongmin Lu; Yilai Shu; Yong Tao; Youg Feng; Dinghua Xie; Weijia Kong; Shiming Yang; Zheng-Yi Chen; Xuezhong Liu
Journal:  Hear Res       Date:  2015-05-15       Impact factor: 3.208

8.  FTO Obesity Variant Circuitry and Adipocyte Browning in Humans.

Authors:  Melina Claussnitzer; Simon N Dankel; Kyoung-Han Kim; Gerald Quon; Wouter Meuleman; Christine Haugen; Viktoria Glunk; Isabel S Sousa; Jacqueline L Beaudry; Vijitha Puviindran; Nezar A Abdennur; Jannel Liu; Per-Arne Svensson; Yi-Hsiang Hsu; Daniel J Drucker; Gunnar Mellgren; Chi-Chung Hui; Hans Hauner; Manolis Kellis
Journal:  N Engl J Med       Date:  2015-08-19       Impact factor: 91.245

9.  Discovery and Functional Characterization of Diverse Class 2 CRISPR-Cas Systems.

Authors:  Sergey Shmakov; Omar O Abudayyeh; Kira S Makarova; Yuri I Wolf; Jonathan S Gootenberg; Ekaterina Semenova; Leonid Minakhin; Julia Joung; Silvana Konermann; Konstantin Severinov; Feng Zhang; Eugene V Koonin
Journal:  Mol Cell       Date:  2015-10-22       Impact factor: 17.970

10.  Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing.

Authors:  Dirk Heckl; Monika S Kowalczyk; David Yudovich; Roger Belizaire; Rishi V Puram; Marie E McConkey; Anne Thielke; Jon C Aster; Aviv Regev; Benjamin L Ebert
Journal:  Nat Biotechnol       Date:  2014-06-22       Impact factor: 54.908

View more
  16 in total

1.  Biomedical applications of gene editing.

Authors:  Pablo Perez-Pinera; Zheng-Yi Chen
Journal:  Hum Genet       Date:  2016-09       Impact factor: 4.132

Review 2.  Mapping and editing animal mitochondrial genomes: can we overcome the challenges?

Authors:  Anna Klucnika; Hansong Ma
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-12-02       Impact factor: 6.237

Review 3.  Diagnostic and therapeutic applications of genomic medicine in progressive, late-onset, nonsyndromic sensorineural hearing loss.

Authors:  Joaquin E Jimenez; Aida Nourbakhsh; Brett Colbert; Rahul Mittal; Denise Yan; Carlos L Green; Eric Nisenbaum; George Liu; Nicole Bencie; Jason Rudman; Susan H Blanton; Xue Zhong Liu
Journal:  Gene       Date:  2020-04-15       Impact factor: 3.688

4.  Easi-CRISPR for creating knock-in and conditional knockout mouse models using long ssDNA donors.

Authors:  Hiromi Miura; Rolen M Quadros; Channabasavaiah B Gurumurthy; Masato Ohtsuka
Journal:  Nat Protoc       Date:  2017-12-21       Impact factor: 13.491

Review 5.  CRISPR/Cas9 in zebrafish: an efficient combination for human genetic diseases modeling.

Authors:  Jiaqi Liu; Yangzhong Zhou; Xiaolong Qi; Jia Chen; Weisheng Chen; Guixing Qiu; Zhihong Wu; Nan Wu
Journal:  Hum Genet       Date:  2016-11-02       Impact factor: 4.132

Review 6.  Recent Advancements in the Regeneration of Auditory Hair Cells and Hearing Restoration.

Authors:  Rahul Mittal; Desiree Nguyen; Amit P Patel; Luca H Debs; Jeenu Mittal; Denise Yan; Adrien A Eshraghi; Thomas R Van De Water; Xue Z Liu
Journal:  Front Mol Neurosci       Date:  2017-07-31       Impact factor: 5.639

7.  Generation and Genetic Correction of USH2A c.2299delG Mutation in Patient-Derived Induced Pluripotent Stem Cells.

Authors:  Xuezhong Liu; Justin Lillywhite; Wenliang Zhu; Zaohua Huang; Anna M Clark; Nicholas Gosstola; Colin T Maguire; Derek Dykxhoorn; Zheng-Yi Chen; Jun Yang
Journal:  Genes (Basel)       Date:  2021-05-25       Impact factor: 4.096

8.  i-GONAD: a robust method for in situ germline genome engineering using CRISPR nucleases.

Authors:  Masato Ohtsuka; Masahiro Sato; Hiromi Miura; Shuji Takabayashi; Makoto Matsuyama; Takayuki Koyano; Naomi Arifin; Shingo Nakamura; Kenta Wada; Channabasavaiah B Gurumurthy
Journal:  Genome Biol       Date:  2018-02-26       Impact factor: 13.583

9.  Easi-CRISPR: a robust method for one-step generation of mice carrying conditional and insertion alleles using long ssDNA donors and CRISPR ribonucleoproteins.

Authors:  Rolen M Quadros; Hiromi Miura; Donald W Harms; Hisako Akatsuka; Takehito Sato; Tomomi Aida; Ronald Redder; Guy P Richardson; Yutaka Inagaki; Daisuke Sakai; Shannon M Buckley; Parthasarathy Seshacharyulu; Surinder K Batra; Mark A Behlke; Sarah A Zeiner; Ashley M Jacobi; Yayoi Izu; Wallace B Thoreson; Lisa D Urness; Suzanne L Mansour; Masato Ohtsuka; Channabasavaiah B Gurumurthy
Journal:  Genome Biol       Date:  2017-05-17       Impact factor: 13.583

10.  Successful production of genome-edited rats by the rGONAD method.

Authors:  Tomoe Kobayashi; Masumi Namba; Takayuki Koyano; Masaki Fukushima; Masahiro Sato; Masato Ohtsuka; Makoto Matsuyama
Journal:  BMC Biotechnol       Date:  2018-04-02       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.